Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1064
Active ingredient: Alisertib
Indication: Treatment of ovarian cancer
Sponsor: Takeda Development Centre Europe Ltd
61 Aldwych, London WC2B 4AE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Orphan designation EMA/OD/114/12 (2012)8197 of 8/11/2012
12/11/2013 Change of name and/or address of sponsor
28/11/2016 Removal of orphan designation from Community Register